Aciont, Inc. is a biotechnology company specializing in developing and commercializing innovative drug delivery technologies for ophthalmic applications. The company's proprietary technologies aim to improve the effectiveness and convenience of ocular drug delivery, offering solutions for various eye conditions. Aciont's goal is to revolutionize the way drugs are administered in the eye, ultimately improving patient outcomes and quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#155 in Salt Lake City, UT

#403 in Utah

#32,605 in US

Salt Lake City, UT, United States of America

Aciont, Inc.

Forward Citations = 406

8 inventors:

John W Higuchi (5 out of 5 patents)

William I Higuchi (5 out of 10 patents)

S Kevin Li (4 out of 6 patents)

4. David J Miller (4 out of 4 patents)

5. Kevin Li (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aciont, Inc.. Retrieved from https://idiyas.com/company/aciont

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]